WAVE Life Sciences Ltd.
WVE
$6.73
-$0.06-0.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.25M | -61.78M | -32.92M | -31.56M | -16.26M |
| Total Depreciation and Amortization | 2.16M | 2.16M | 2.17M | 2.18M | 2.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.24M | 3.53M | 3.49M | 2.88M | 2.35M |
| Change in Net Operating Assets | -78.30M | 9.61M | -202.00K | -6.93M | -21.52M |
| Cash from Operations | -43.65M | -46.48M | -27.47M | -33.43M | -33.24M |
| Capital Expenditure | -86.00K | -383.00K | -52.00K | -417.00K | -356.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -86.00K | -383.00K | -52.00K | -417.00K | -356.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.01M | 189.65M | 653.00K | 14.51M | 93.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.00K | 14.10M | -- | -- | -- |
| Cash from Financing | 34.98M | 203.75M | 653.00K | 14.51M | 93.96M |
| Foreign Exchange rate Adjustments | -103.00K | 120.00K | -81.00K | -74.00K | 58.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.86M | 157.01M | -26.95M | -19.41M | 60.43M |